NOTICE OF ALLOWANCE - ISSUED
issued
on 06 Aug 2024
Last Applicant/ Owned by
1111 Main Street
Vancouver
WA
98660
Serial Number
98115520 filed on 03rd Aug 2023
Registration Number
N/A
Correspondent Address
Jared M. Barrett
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
LIVIMMUNE
Scientific research consulting services, namely, scientific research consulting services in the field of immunology, and scientific research consulting services in the field of therapeutic agents, preparations and substances for the prevention and/or treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, Read More
Classification Information
Class [044]
Medical, Beauty & Agricultural Services
Providing health and medical information, and providing health and medical information in the nature of providing a website featuring information in the field of therapeutic agents, preparations and substances for the prevention and/or treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19; providing a website featuring medical information; providing a website featuring medical information in the field of antibodies for use in targeting the CCR5 cell receptor; medical analysis services, namely, medical analysis services in the field of antibodies for use in targeting the CCR5 cell receptor, and medical analysis services in the field of therapeutic agents, preparations and substances for the prevention and/or treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [042]
Computer & Software Services & Scientific Services
Scientific research consulting services, namely, scientific research consulting services in the field of immunology, and scientific research consulting services in the field of therapeutic agents, preparations and substances for the prevention and/or treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19; medical research services, and medical research services in the field of therapeutic agents, preparations and substances for the prevention and/or treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19; medical research services in the field of antibodies for use in targeting the CCR5 cell receptor
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [005]
Pharmaceutical Products
Therapeutic preparations, namely, therapeutic preparations for the treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19, and therapeutic preparations for the prevention of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19; therapeutic preparations, namely, antibodies for use in targeting the CCR5 cell receptor
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 98115520
Mark Type
No Service Mark
Attorney Docket Number
No 230042.234
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 06th Aug 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 11th Jun 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 11th Jun 2024 | PUBLISHED FOR OPPOSITION |
| 22nd May 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 06th May 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 04th Apr 2024 | ASSIGNED TO EXAMINER |
| 01st Sep 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| 07th Aug 2023 | NEW APPLICATION ENTERED |